What is the treatment for urethritis?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Treatment of Urethritis

The first-line treatment for urethritis is either azithromycin 1g orally in a single dose or doxycycline 100mg orally twice daily for 7 days. 1, 2

Diagnosis

Before initiating treatment, urethritis should be confirmed by at least one of the following:

  • Mucopurulent or purulent urethral discharge 1
  • Gram stain of urethral secretions showing ≥5 WBC per oil immersion field 1
  • Positive leukocyte esterase test on first-void urine 1
  • Microscopic examination of first-void urine showing ≥10 WBC per high-power field 1

All patients with confirmed or suspected urethritis should be tested for both Neisseria gonorrhoeae and Chlamydia trachomatis to guide appropriate treatment 1, 2

Treatment Recommendations

First-Line Regimens

  • Azithromycin 1g orally in a single dose 1, 2, 3
    • Advantages: Single-dose regimen improves compliance and allows for directly observed therapy 1, 4
    • Particularly effective against Mycoplasma genitalium 1, 5
  • OR
  • Doxycycline 100mg orally twice daily for 7 days 1, 2
    • Highly effective for chlamydial urethritis 1

Alternative Regimens (if first-line options cannot be used)

  • Erythromycin base 500mg orally four times daily for 7 days 1
  • OR
  • Erythromycin ethylsuccinate 800mg orally four times daily for 7 days 1
  • OR
  • Levofloxacin 500mg orally once daily for 7 days 1
  • OR
  • Ofloxacin 300mg orally twice daily for 7 days 1

Management Considerations

  • Treatment should be initiated as soon as possible after diagnosis 1
  • Medications should ideally be dispensed on-site in the clinic, with the first dose directly observed to maximize compliance 1
  • Patients should abstain from sexual intercourse for 7 days after single-dose therapy or until completion of a 7-day regimen, provided their symptoms have resolved 1
  • All sexual partners within the preceding 60 days should be referred for evaluation and treatment 1, 2
  • Patients should be instructed to return for evaluation if symptoms persist or recur after completion of therapy 1

Special Considerations

Empiric Treatment

  • Empiric treatment without documentation of urethritis is recommended only for patients at high risk for infection who are unlikely to return for follow-up 1
  • Such patients should be treated for both gonorrhea and chlamydia 1

Persistent or Recurrent Urethritis

  • Objective signs of urethritis should be present before initiating additional antimicrobial therapy 6
  • Consider testing for Trichomonas vaginalis using an intraurethral swab or first-void urine specimen 6
  • Treatment options for persistent/recurrent urethritis:
    • Metronidazole 2g orally in a single dose OR tinidazole 2g orally in a single dose 6
    • PLUS azithromycin 1g orally in a single dose (if not used for initial episode) 6, 5

Common Pitfalls to Avoid

  • Treating based on symptoms alone without confirming objective signs of urethritis 6
  • Failing to test for both gonorrhea and chlamydia 1, 2
  • Failing to address possible reinfection from untreated partners 6
  • Persistence of pain, discomfort, and irritative voiding symptoms beyond 3 months should alert the clinician to the possibility of chronic prostatitis/chronic pelvic pain syndrome 1, 6

Clinical Efficacy

Clinical cure rates are comparable between azithromycin (81%) and doxycycline (77%) regimens, regardless of whether Chlamydia or Ureaplasma infection is present 4. Both treatments are generally well-tolerated with mild to moderate adverse effects 4.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Urethritis Treatment Guidelines

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of non-gonococcal urethritis.

BMC infectious diseases, 2015

Guideline

Management of Persistent Urethritis Despite Doxycycline Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.